The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.9, 2009-09, pp. : 705-712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics and the Evolution of Healthcare: Is it Time for Cost-Effectiveness Analysis at the Individual Level?

By Bala M.V.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 495-498

Adis International

Access to resources Recommend Favorite

Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?

By Adam La Caze

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 445-447

Adis International

Access to resources Recommend Favorite

The (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses: Fact or Fallacy?

By Donaldson C.

PharmacoEconomics, Vol. 13, Iss. 4, 1998-04 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite

The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics

By Flowers C.R. Veenstra D.

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 481-493

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?

By Mauskopf J.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite